NexPoint Life Sciences III DST
Investment Description
NexPoint Life Sciences III DST holds a single-tenant research and development facility in Woodbury, Minnesota. Kindeva is identified as the property tenant. The offering is structured as a Delaware statutory trust, with investor interests linked to the real estate and its disclosed master-lease arrangements.
Key Facts
- Fundraising Status
- Open
- Sponsor Name
- NexPoint
- Location(s)
- Minnesota
- Equity
- $30,661,253
- Debt
- $31,300,000
- LTV (investor offering)
- 50.52%
- Property Type
- Medical research and development
Source-document projections, not actual distributions. Income is operating cash divided by original offering equity and excludes sale proceeds. Y1 and the average use the detailed nine-year investor cash schedule; no tenth year is supplied. Offering LTV = allocated debt / (offering equity + allocated debt). Figures reflect reviewed document dates, not current operating results. Projections are not guaranteed; availability is maintained separately.
Sponsor Overview
NexPoint
NexPoint is the investment platform identified in the offering materials. Its real-estate activities include multifamily housing and other commercial property sectors. Affiliated entities serve in sponsor, asset-management and trust-management roles as described in the offering documents.